HEX

File: D:/hMailServer/Data/showfile.com/admin/94/{94AF7649-0CAE-4748-BCC3-8844615C5157}.eml
From: =?UTF-8?B?VGhlIEJ1c2luZXNzIEludmVzdG9y?= <thebusinessinvestor1@email.thebusinessinvestor.co.uk>
Reply-To: thebusinessinvestor1@gmail.com
To: vince@showfile.com
Subject: Tax-efficient investment | Cancer diagnostics laboratory
MIME-Version: 1.0
Content-Type: multipart/alternative; 
	boundary="----=_Part_491171_947724845.1782234111465"
Message-ID: <0101019ef56e5de9-6d03aa53-3ea5-4658-8b90-84c970c0db3e-000000@us-west-2.amazonses.com>
Date: Tue, 23 Jun 2026 17:01:51 +0000
Feedback-ID: ::1.us-west-2.FY2JHzuHteH24rwV/wYvgt9579zoNW+LqMsjgruyFCY=:AmazonSES

------=_Part_491171_947724845.1782234111465
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 7bit

Hello,

We are pleased to share an opportunity to invest in the next generation of
cancer screening, while benefiting from generous tax incentives available to
company directors.

Frontier Diagnostics is at the forefront of cancer screening and is seeking
investors to help transform the landscape of cancer detection and treatment.

Investment Highlights:

* Diagnostics platform built on ISO-accredited laboratory infrastructure
* Clinics send us the samples, and we return results in 5 days
* Larger sites can use our Quantum Fluoscope device for in-house testing
* Huge market potential with a worldwide sales pipeline in place
* and much more...
EIS approved efficiencies:

* 30% Income Tax Relief*
* Free from Capital Gains*
* Inheritance Tax Relief*
* Loss Relief*
If the above is of interest, please let us know by replying to this email or
filling in our .

Kind regards,

The Business Investor

*If applicable
Disclaimer: Any person accessing the email and considering potential investment
opportunities featured in the email should make their own commercial assessment
after seeking the advice of an appropriately authorised or regulated financial
adviser. This email should not be construed as advice or a personal
recommendation to any prospective investor. Investments of this nature carry
risks to your capital and can go up or down. Past performance is not indicative
of future results. This opportunity is only suitable for high net worth or
self-sophisticated investors as defined below. You have an annual income in
excess of ?100K. Have net assets in excess of ?250K (excluding your pension
funds and assets and your private residence). You have been a Director of a
company turning over at least ?1 million within the last two years. You have
made more than one investment in an unlisted company in the previous two years.
You have been a member of a network or syndicate of business angels for at least
six months. You have worked in the last two years in a professional capacity in
the private equity sector or in the provision of finance for small and medium
enterprises.
------=_Part_491171_947724845.1782234111465
Content-Type: text/html; charset=UTF-8
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html><html xmlns=3D"http://www.w3.org/1999/xhtml" xmlns:v=3D"urn:=
schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-microsoft-com:office:offi=
ce"><head>
<!--[if gte mso 9]>
<xml>
  <o:OfficeDocumentSettings>
    <o:AllowPNG/>
    <o:PixelsPerInch>96</o:PixelsPerInch>
  </o:OfficeDocumentSettings>
</xml>
<![endif]-->
  <meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8">
  <meta name=3D"viewport" content=3D"width=3Ddevice-width, initial-scale=3D=
1.0">
  <meta name=3D"x-apple-disable-message-reformatting">
  <!--[if !mso]><!--><meta http-equiv=3D"X-UA-Compatible" content=3D"IE=3De=
dge"><!--<![endif]-->
  <title></title>
 =20
    <style type=3D"text/css">
     =20
      @media only screen and (min-width: 520px) {
        .u-row {
          width: 500px !important;
        }

        .u-row .u-col {
          vertical-align: top;
        }

       =20
            .u-row .u-col-100 {
              width: 500px !important;
            }
         =20
      }

      @media only screen and (max-width: 520px) {
        .u-row-container {
          max-width: 100% !important;
          padding-left: 0px !important;
          padding-right: 0px !important;
        }

        .u-row {
          width: 100% !important;
        }

        .u-row .u-col {
          display: block !important;
          width: 100% !important;
          min-width: 320px !important;
          max-width: 100% !important;
        }

        .u-row .u-col > div {
          margin: 0 auto;
        }


}
   =20
body{margin:0;padding:0}table,td,tr{border-collapse:collapse;vertical-align=
:top}.ie-container table,.mso-container table{table-layout:fixed}*{line-hei=
ght:inherit}a[x-apple-data-detectors=3Dtrue]{color:inherit!important;text-d=
ecoration:none!important}


table, td { color: #000000; } #u_body a { color: #0000ee; text-decoration: =
underline; }
    </style>
 =20
 =20

<!--[if !mso]><!--><link href=3D"https://fonts.googleapis.com/css?family=3D=
Montserrat:400,700" rel=3D"stylesheet" type=3D"text/css"><!--<![endif]-->

</head>

<body class=3D"clean-body u_body" style=3D"margin: 0;padding: 0;-webkit-tex=
t-size-adjust: 100%;background-color: #F7F8F9;color: #000000"><div style=3D=
"display:none; max-height:0; overflow:hidden; mso-hide:all; visibility:hidd=
en;">Successful cancer screening lab EIS approved</div>
  <!--[if IE]><div class=3D"ie-container"><![endif]-->
  <!--[if mso]><div class=3D"mso-container"><![endif]-->
  <table role=3D"presentation" id=3D"u_body" style=3D"border-collapse: coll=
apse;table-layout: fixed;border-spacing: 0;mso-table-lspace: 0pt;mso-table-=
rspace: 0pt;vertical-align: top;min-width: 320px;Margin: 0 auto;background-=
color: #F7F8F9;width:100%" cellpadding=3D"0" cellspacing=3D"0">
  <tbody>
  <tr style=3D"vertical-align: top">
    <td style=3D"word-break: break-word;border-collapse: collapse !importan=
t;vertical-align: top">
    <!--[if (mso)|(IE)]><table role=3D"presentation" width=3D"100%" cellpad=
ding=3D"0" cellspacing=3D"0" border=3D"0"><tr><td align=3D"center" style=3D=
"background-color: #F7F8F9;"><![endif]-->
   =20
 =20
 =20
<div class=3D"u-row-container" style=3D"padding: 0px;background-color: tran=
sparent">
  <div class=3D"u-row" style=3D"margin: 0 auto;min-width: 320px;max-width: =
500px;overflow-wrap: break-word;word-wrap: break-word;word-break: break-wor=
d;background-color: transparent;">
    <div style=3D"border-collapse: collapse;display: table;width: 100%;heig=
ht: 100%;background-color: transparent;">
      <!--[if (mso)|(IE)]><table role=3D"presentation" width=3D"100%" cellp=
adding=3D"0" cellspacing=3D"0" border=3D"0"><tr><td style=3D"padding: 0px;b=
ackground-color: transparent;" align=3D"center"><table role=3D"presentation=
" cellpadding=3D"0" cellspacing=3D"0" border=3D"0" style=3D"width:500px;"><=
tr style=3D"background-color: transparent;"><![endif]-->
     =20
<!--[if (mso)|(IE)]><td align=3D"center" width=3D"500" style=3D"width: 500p=
x;padding: 0px;border-top: 0px solid transparent;border-left: 0px solid tra=
nsparent;border-right: 0px solid transparent;border-bottom: 0px solid trans=
parent;border-radius: 0px;-webkit-border-radius: 0px; -moz-border-radius: 0=
px;" valign=3D"top"><![endif]-->
<div class=3D"u-col u-col-100" style=3D"max-width: 320px;min-width: 500px;d=
isplay: table-cell;vertical-align: top;">
  <div style=3D"height: 100%;width: 100% !important;border-radius: 0px;-web=
kit-border-radius: 0px; -moz-border-radius: 0px;">
  <!--[if (!mso)&(!IE)]><!--><div style=3D"box-sizing: border-box; height: =
100%; padding: 0px;border-top: 0px solid transparent;border-left: 0px solid=
 transparent;border-right: 0px solid transparent;border-bottom: 0px solid t=
ransparent;border-radius: 0px;-webkit-border-radius: 0px; -moz-border-radiu=
s: 0px;"><!--<![endif]-->
 =20
<table style=3D"font-family:arial,helvetica,sans-serif;" role=3D"presentati=
on" cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" border=3D"0">
  <tbody>
    <tr>
      <td style=3D"overflow-wrap:break-word;word-break:break-word;padding:1=
0px;font-family:arial,helvetica,sans-serif;" align=3D"left">
       =20
  <div style=3D"font-size: 14px; line-height: 140%; text-align: left; word-=
wrap: break-word;">
    <p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family=
: Montserrat, sans-serif; line-height: 19.6px;"><strong>Hello,</strong></sp=
an></p>
<p style=3D"line-height: 140%; margin: 0px;">&nbsp;</p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: Mo=
ntserrat, sans-serif; line-height: 19.6px;">We are pleased to share an oppo=
rtunity to invest in the next generation of cancer screening, while benefit=
ing from generous tax incentives available to company directors.</span></p>
<p style=3D"line-height: 140%; margin: 0px;">&nbsp;</p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: Mo=
ntserrat, sans-serif; line-height: 19.6px;"><strong>Frontier Diagnostics</s=
trong> is at the forefront of cancer screening and is seeking investors to =
help transform the landscape of cancer detection and treatment.</span></p>
<p style=3D"line-height: 140%; margin: 0px;">&nbsp;</p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: Mo=
ntserrat, sans-serif; line-height: 19.6px;"><strong>Investment Highlights:<=
/strong></span></p>
<ul>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">Diag=
nostics platform built on <strong>ISO-accredited laboratory infrastructure<=
/strong></span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">Clin=
ics send us the samples, and we return results in <strong>5 days</strong></=
span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">Larg=
er sites can use our <strong>Quantum Fluoscope device</strong> for in-house=
 testing</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">Huge=
 market potential with a <strong>worldwide sales pipeline</strong> in place=
</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">and =
much more...</span></li>
</ul>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: Mo=
ntserrat, sans-serif; line-height: 19.6px;"><strong>EIS approved efficienci=
es:</strong></span></p>
<ul>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">30% =
Income Tax Relief*</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">Free=
 from Capital Gains*</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">Inhe=
ritance Tax Relief*</span></li>
<li style=3D"line-height: 19.6px; font-family: Montserrat, sans-serif;"><sp=
an style=3D"font-family: Montserrat, sans-serif; line-height: 19.6px;">Loss=
 Relief*</span></li>
</ul>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: Mo=
ntserrat, sans-serif; line-height: 19.6px;">If the above is of interest, pl=
ease let us know by<strong> replying to this email</strong> or <strong>fill=
ing in our </strong><a rel=3D"noopener" href=3D"https://t.email.thebusiness=
investor.co.uk/a/2/Slxd8ZFVhZeJnYD21wNB8Q/hJHqzIi3GNpma3tWOW5cFvPLvoA8LOvJj=
RSu01gUzArglMnaM9-G6P8XIyQ6xuCwlh1vOsNpjZj4KPQa3eSgScyH5hm1eqQqxQjFgqv6o8-m=
PzXi4kVX4skg_-PvZe9-qr3QhaBZcFzZtuTm7fyh5Q" target=3D"_blank">online form</=
a>.</span></p>
<p style=3D"line-height: 140%; margin: 0px;">&nbsp;</p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: Mo=
ntserrat, sans-serif; line-height: 19.6px;"><strong>Kind regards</strong>,<=
/span></p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"font-family: Mo=
ntserrat, sans-serif; line-height: 19.6px;">The Business Investor</span></p=
>
<p style=3D"line-height: 140%; margin: 0px;">&nbsp;</p>
<p style=3D"line-height: 140%; margin: 0px;"><span style=3D"color: rgb(0, 0=
, 0); font-family: Helvetica, Arial, sans-serif; font-size: 11.2px; white-s=
pace: normal; float: none; display: inline; line-height: 15.4px;">*If appli=
cable<br>Disclaimer: Any person accessing the email and considering potenti=
al investment opportunities featured in the email should make their own com=
mercial assessment after seeking the advice of an appropriately authorised =
or regulated financial adviser. This email should not be construed as advic=
e or a personal recommendation to any prospective investor. Investments of =
this nature carry risks to your capital and can go up or down. Past perform=
ance is not indicative of future results. This opportunity is only suitable=
 for high net worth or self-sophisticated investors as defined below. You h=
ave an annual income in excess of ?100K. Have net assets in excess of ?250K=
 (excluding your pension funds and assets and your private residence). You =
have been a Director of a company turning over at least ?1 million within t=
he last two years. You have made more than one investment in an unlisted co=
mpany in the previous two years. You have been a member of a network or syn=
dicate of business angels for at least six months. You have worked in the l=
ast two years in a professional capacity in the private equity sector or in=
 the provision of finance for small and medium enterprises.&nbsp;</span></p=
>
  </div>

      </td>
    </tr>
  </tbody>
</table>

  <!--[if (!mso)&(!IE)]><!--></div><!--<![endif]-->
  </div>
</div>
<!--[if (mso)|(IE)]></td><![endif]-->
      <!--[if (mso)|(IE)]></tr></table></td></tr></table><![endif]-->
    </div>
  </div>
  </div>
 =20


    <!--[if (mso)|(IE)]></td></tr></table><![endif]-->
    </td>
  </tr>
  </tbody>
  </table>
  <!--[if mso]></div><![endif]-->
  <!--[if IE]></div><![endif]-->



<img src=3D"https://t.email.thebusinessinvestor.co.uk/t/2/XnuvoPgSzZUH9ye6z=
THSrQ/aiKLSXB9Sroj6zCkmvOe32Zo3EiOCwIZ5FjyBP33G0SGC0MWuqjIIZFVG4wKAJWnnt0O3=
dnOzJxt-J9LTlpU8U_Q2xjKGnDrwbx7wOeKH8K4FKfdELWGrYHXut41W2MlDMlihnAUdDUFQKxE=
GeDQ2u_ssziNo-cZlyjMVs4XWlS1oHjxYZcY9vj7kkPTxxBP" style=3D"display:none;"><=
/img></body><footer><div style=3D"text-align: center; background-color: whi=
te; padding: 10px;"><a href=3D"https://t.email.thebusinessinvestor.co.uk/u/=
2/Rdnqy2iPXJYPAI2qJEQ-pA/sZ_JFninPkmktOgXyc3EV0-Y93l6qlKFX-DFzFYCe8YzMaotTO=
cSKo2cae--UNDqy6PWwxuj98eHk-AAgGjnMjMYN4ZrppELnNnhAIHso8LtIkg0YRsaTDZEg8Qi6=
qkqzhYwr6V0dRvDfZy-yC0iTRR-U6NYenA64so217SWaye9dS0XR6mQJn4RxDe_v7YbWzliK8h6=
nmwN6TOuSGkr_I7yhgmt8WH9tRJiBwbF-qXkO0v67gQWHyfYCsoy4XkLu4gkD7JDrdZb0KQ0bpv=
YRw">Unsubscribe</a><a href=3D"https://t.email.thebusinessinvestor.co.uk/s/=
2/kkTkXbeIhpv_vJ-PlOrbxw/wd3v4mgyJpjZgNuBGe6lGzJO9Fpz8bjBjvYl_5EXgHeJQYM9Mm=
-uUJfQRS5L-44f0soryvDQeL9T5wfPteDDSBEf7lBvr_lEqapAmX1sXPCokA_stTz-MVdrbYPHy=
ce385244CtFDIOanKEWaUZL5G5u3g5gTkZSM_Y46HBWD1uR7zLF232VbKXd3zbgTMGvKB9akI-c=
lU0rSm0y9NpXEgt6_Axi_JJuXhHrCePxFidjuW5Rtl5zUOHAzzYi-Zmg-RDkAWfIjNEfKrh8jbM=
cJg">Report Abuse</a></div></footer></html>
------=_Part_491171_947724845.1782234111465--